← Back

Tate & Lyle PLC

Tate & Lyle PLC, along with its subsidiaries, supplies ingredients and solutions to the food, beverage, and other industries across North America, Asia, the Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers, functional systems, hydrocolloids, starches, proteins, and functional flours. These products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. The company has a strategic collaboration with BioHarvest Sciences Inc. It was incorporated in 1903 and is headquartered in London, the United Kingdom.

Country
Price · split & dividend adjusted
News & notes moving TATE.LSE
TATE.LSE▲

Ingredion reaffirms 2026 adjusted EPS of $10.30 to $10.90 while progressing Tate & Lyle deal

Ingredion reaffirmed its full-year 2026 adjusted earnings per share guidance of $10.30 to $10.90, reflecting the sale of its majority stake in the Pakistan business. The company reported second-quarter net sales of $1.85 billion, up 1% from the prior year, with Texture & Healthful Solutions volume growth accelerating to 7%. Ingredion also announced that Tate & Lyle shareholders approved its all-cash offer, and the transaction is expected to deliver $130 million of run-rate synergies by 2030 and greater than 15% adjusted EPS accretion in the first full calendar year post-acquisition. Adjusted operating income for the quarter was $258 million, while cash from operations for the full year is now anticipated to be between $700 million and $800 million. Capital expenditures are expected to range from $450 million to $490 million, with additional spend allocated to the Argo facility.
INGR · Capital · Positive Reaffirms 2026 EPS guidance and reports Q2 results with volume growth.
TATE.LSE · Capital · Positive Shareholders approved all-cash offer, expected to deliver synergies and EPS accretion.
Read original ↗
Seeking Alpha·61dRead more →
TATE.LSE2

Pzena Investment Management Discloses 3.56% Stake in Tate & Lyle

Pzena Investment Management, LLC disclosed a 3.56% interest in Tate & Lyle Plc, holding 15,869,502 ordinary 10p shares as of July 20, 2026. The disclosure, made under Rule 8.3 of the Takeover Code, also reported a sale of 97,568 shares at £5.59 per share. No cash-settled or stock-settled derivatives were held, and no indemnity or other dealing arrangements were in place.
TATE.LSE · Capital · Neutral Pzena disclosed a 3.56% stake and a small sale; no clear positive or negative signal for Tate & Lyle.
Read original ↗
Business Wire·76dRead more →
TATE.LSE▲2

Millennium International Management LP discloses 3.437% stake in Tate & Lyle plc

Millennium International Management LP has disclosed a 3.437% interest in Tate & Lyle plc through cash-settled derivatives, according to a regulatory filing dated June 24, 2026. The position, held as of June 23, 2026, comprises 15,311,759 reference securities in the 29 1/6p ordinary shares, with no relevant securities owned directly. The filing details multiple equity swap transactions on June 23, including closing a short position of 1,974,492 shares at 5.54 GBP and opening or increasing long positions totaling 1,679,456 shares at prices of 5.54 and 5.55 GBP. No stock-settled derivatives or other arrangements were reported.
TATE.LSE · Capital · Positive Millennium Management disclosed a 3.437% stake via derivatives, indicating institutional interest and potential bullish sentiment.
Read original ↗
Business Wire·102dRead more →
TATE.LSE▲

Jim Cramer Says Ingredion Will Become an Ingredient Powerhouse After Tate & Lyle Deal

Jim Cramer highlighted Ingredion on Mad Money, arguing the market is overlooking its $3.6 billion cash acquisition of British ingredients company Tate & Lyle. He noted that Ingredion, which makes flavors and textures for the food and beverage industries, has a market capitalization of only $6.2 billion, making this a transformative deal that will create a powerhouse in the ingredients space. Cramer pointed out that the stock is down 10% for the year, partly due to an imperfect quarter in early May, but he believes the merger will make Ingredion the most important company in its industry.
INGR · Capital · Positive Ingredion is acquiring Tate & Lyle in a transformative $3.6B cash deal, which Cramer says will make it a powerhouse.
TATE.LSE · Capital · Positive Tate & Lyle is being acquired by Ingredion for $3.6B cash, a premium to its market value.
Read original ↗
Insider Monkey·106dRead more →